Justin Lee

Justin Lee

Auto-generated profile, based on publicly available information

Justin Lee

Department of Cardiovascular Medicine, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in JACC
Verified
Journal Article
Closed access
JLJustin M.S. Lee
Justin M.S. Lee
MRMatthew D. Robson
Matthew D. Robson
LYLy-Mee Yu
Ly-Mee Yu
CSCheerag C. Shirodaria
Cheerag C. Shirodaria
CCColin Cunnington
Colin Cunnington
RCRobin P. Choudhury
Robin P. Choudhury

20 March 2012 in Circulation
Verified
Journal Article
Open access
PDF file
CCColin Cunnington
Colin Cunnington
TATim Van Assche
Tim Van Assche
CSCheerag Shirodaria
Cheerag Shirodaria
IKIlias Kylintireas
Ilias Kylintireas
ALAlistair C. Lindsay
Alistair C. Lindsay
KCKeith M. Channon
Keith M. Channon
Background—: The endothelial nitric oxide synthase cofactor tetrahydrobiopterin (BH4) plays a pivotal role in maintaining endothelial function in experimental vascular disease models and in humans. Augmentation of endogenous BH4 levels by oral BH4 treatment has been proposed as a potential therapeutic strategy in vascular disease states. We sought to determine the mechanisms relating exogenous BH4 to human vascular function and to determine oral BH4 pharmacokinetics in both plasma and vascular tissue in patients with coronary artery disease. Methods and Results—: Forty-nine patients with coronary artery disease were randomized to receive low-dose (400 mg/d) or high-dose (700 mg/d) BH4 or placebo for 2 to 6 weeks before coronary artery bypass surgery. Vascular function was quantified by magnetic resonance imaging before and after treatment, along with plasma BH4 levels. Vascular superoxide, endothelial function, and BH4 levels were determined in segments of saphenous vein and internal mammary artery. Oral BH4 treatment significantly augmented BH4 levels in plasma and in saphenous vein (but not internal mammary artery) but also increased levels of the oxidation product dihydrobiopterin (BH2), which lacks endothelial nitric oxide synthase cofactor activity. There was no effect of BH4 treatment on vascular function or superoxide production. Supplementation of human vessels and blood with BH4 ex vivo revealed rapid oxidation of BH4 to BH2 with predominant BH2 uptake by vascular tissue. Conclusions—: Oral BH4 treatment augments total biopterin levels in patients with established coronary artery disease but has no net effect on vascular redox state or endothelial function owing to systemic and vascular oxidation of BH4. Alternative strategies are required to target BH4-dependent endothelial function in established vascular disease states. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00423280.

1 December 2012 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
SKSaurabh Kumar
Saurabh Kumar
JMJoseph B. Morton
Joseph B. Morton
JLJustin Lee
Justin Lee
KHKaren Halloran
Karen Halloran
SSSteven J. Spence
Steven J. Spence
JKJonathan M. Kalman
Jonathan M. Kalman
Background—: Catheter–tissue contact is critical for effective lesion creation. We characterized the contact force (CF) at different anatomic sites during antral pulmonary vein (PV) isolation for atrial fibrillation. Methods and Results—: Two experienced operators performed PV isolation in 22 patients facilitated by a novel CF-sensing ablation catheter in a blinded fashion. Average CF and force-time integral data from 1602 lesions were analyzed. The left and right PV antra were divided into the following: carina, superior, inferior, anterior, and posterior quadrants for analysis. There was significant variability in CF within and between different PV quadrants ( P <0.05). Lowest CF of all left PV sites was at the carina and anterior quadrant, whereas highest CF was at the superior and inferior quadrants ( P <0.05). Lowest CF of all right PV sites was at the carina, whereas highest CF was at the anterior and inferior quadrants ( P <0.05). When comparing similar PV quadrants on the left versus right (eg, left carina versus right carina), CF was always higher in the right PVs ( P <0.05), except at the superior quadrant where CF was similar in the left and right PVs ( P =0.19). There was no specific pattern of anatomic distribution of excess CF ( P =0.39). Conclusions—: Monitoring of catheter–tissue CF during PV isolation demonstrates significant variability in CF within and between different PV antral sites. Sites of lowest CF were the carina and anterior left PVs and the carina of the right PVs. This information may be important for improving ablation efficacy and clinical outcomes during PV isolation.

4 November 2017 in Anaesthesia
Verified
Journal Article
Closed access
PDF file
RCR. Chebbout
R. Chebbout
EHE. G. Heywood
E. G. Heywood
TDT. M. Drake
T. M. Drake
JWJ. R. L. Wild
J. R. L. Wild
JLJ. Lee
J. Lee
MLM. J. Lee
M. J. Lee

1 April 2012 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
ALAlistair C. Lindsay
Alistair C. Lindsay
LBLuca Biasiolli
Luca Biasiolli
JLJustin M.S. Lee
Justin M.S. Lee
IKIlias Kylintireas
Ilias Kylintireas
BMBradley J. MacIntosh
Bradley J. MacIntosh
RCRobin P. Choudhury
Robin P. Choudhury

1 July 2013 in Heart Rhythm
Verified
Journal Article
Closed access
SKSaurabh Kumar
Saurabh Kumar
HHH.M. Haqqani
H.M. Haqqani
MCMartin Chan
Martin Chan
JLJustin Lee
Justin Lee
MYMatias Yudi
Matias Yudi
JKJonathan M. Kalman
Jonathan M. Kalman